top of page

logo_blue & gold.png

Abstract Structure

Transaction and News

Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer

December 22, 2022 at 1:22:57 PM

Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited

December 12, 2022 at 5:08:14 AM

China Pharma Holdings Acquires Dry Eye Disease Therapeutic Device Project

December 8, 2022 at 2:09:12 PM

Baozun Acquires Gap Greater China and Establishes Brand Management as a New Business Line

November 10, 2022 at 8:27:49 AM

China Resources Beer to Acquire Baijiu Maker for $1.7bn

October 28, 2022 at 6:13:47 AM

Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and Commercialization of Intratumoral Immunotherapy

October 18, 2022 at 1:33:05 AM

Abstract Structure

bottom of page